239 related articles for article (PubMed ID: 33392181)
21. The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis.
Weng NQ; Chi J; Wen J; Mai SJ; Zhang MY; Huang L; Liu J; Yang XZ; Xu GL; Fu JH; Wang HY
J Transl Med; 2020 Jan; 18(1):47. PubMed ID: 32005248
[TBL] [Abstract][Full Text] [Related]
22. Identification and validation of neurotrophic factor-related genes signature in HNSCC to predict survival and immune landscapes.
Peng G; Chi H; Gao X; Zhang J; Song G; Xie X; Su K; Song B; Yang J; Gu T; Li Y; Xu K; Li H; Liu Y; Tian G
Front Genet; 2022; 13():1010044. PubMed ID: 36406133
[No Abstract] [Full Text] [Related]
23. Comprehensive Analysis of TRP Channel-Related Genes for Estimating the Immune Microenvironment, Prognosis, and Therapeutic Effect in Patients With Esophageal Squamous Cell Carcinoma.
Zhao F; Gao S; Qin X; Niu R; Li Z; Wang C; Li S
Front Cell Dev Biol; 2022; 10():820870. PubMed ID: 35309940
[TBL] [Abstract][Full Text] [Related]
24. A novel immune-related gene signature predicts survival in esophageal squamous cell carcinoma.
Xu T; Dai T; Zeng P; Guo Y; He K
Transl Cancer Res; 2021 May; 10(5):2354-2367. PubMed ID: 35116551
[TBL] [Abstract][Full Text] [Related]
25. Identification and validation of a prognostic signature of cuproptosis-related genes for esophageal squamous cell carcinoma.
Zhang Y; Chen K; Wang L; Chen J; Lin Z; Chen Y; Chen J; Lin Y; Xu Y; Peng H
Aging (Albany NY); 2023 Sep; 15(17):8993-9021. PubMed ID: 37665670
[TBL] [Abstract][Full Text] [Related]
26. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma.
Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H
Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376
[TBL] [Abstract][Full Text] [Related]
27. Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma.
Zhao F; Li Z; Dong Z; Wang Z; Guo P; Zhang D; Li S
Front Immunol; 2022; 13():918154. PubMed ID: 35880180
[TBL] [Abstract][Full Text] [Related]
28. Identification and Validation of a Four-Gene Ferroptosis Signature for Predicting Overall Survival of Lung Squamous Cell Carcinoma.
Wang Q; Chen Y; Gao W; Feng H; Zhang B; Wang H; Lu H; Tan Y; Dong Y; Xu M
Front Oncol; 2022; 12():933925. PubMed ID: 35912252
[TBL] [Abstract][Full Text] [Related]
29. Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis.
Qiang W; Dai Y; Xing X; Sun X
Cancer Med; 2022 Aug; 11(16):3168-3181. PubMed ID: 35301800
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of a five-lncRNA signature in esophageal squamous cell carcinoma.
Zhang L; Li P; Liu E; Xing C; Zhu D; Zhang J; Wang W; Jiang G
Cancer Cell Int; 2020; 20():386. PubMed ID: 32831646
[TBL] [Abstract][Full Text] [Related]
31. From pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer.
Li B; Qin W; Yang L; Li H; Jiang C; Yao Y; Cheng S; Zou B; Fan B; Dong T; Wang L
J Transl Med; 2024 Feb; 22(1):195. PubMed ID: 38388379
[TBL] [Abstract][Full Text] [Related]
32. An Immune Cell-Based Signature Associating With EMT Phenotype Predicts Postoperative Overall Survival of ESCC.
Yu H; Gu D; Yue C; Xu J; Yan F; He X
Front Oncol; 2021; 11():636479. PubMed ID: 33869022
[TBL] [Abstract][Full Text] [Related]
33. Determination of a prediction model for therapeutic response and prognosis based on chemokine signaling-related genes in stage I-III lung squamous cell carcinoma.
Lai J; Yang S; Chu S; Xu T; Huang J
Front Genet; 2022; 13():921837. PubMed ID: 36118890
[No Abstract] [Full Text] [Related]
34. A Prognostic Signature Based on Immunogenomic Profiling Offers Guidance for Esophageal Squamous Cell Cancer Treatment.
Gao J; Tang T; Zhang B; Li G
Front Oncol; 2021; 11():603634. PubMed ID: 33718151
[TBL] [Abstract][Full Text] [Related]
35. A novel DNA damage repair gene-related prognostic model for evaluating the prognosis and tumor microenvironment infiltration of esophageal squamous cell carcinoma.
Guo D; Zhang X; Du X; Yao W; Shen W; Zhu S
BMC Med Genomics; 2023 Feb; 16(1):27. PubMed ID: 36803971
[TBL] [Abstract][Full Text] [Related]
36. The Prognostic Signature of Head and Neck Squamous Cell Carcinoma Constructed by Immune-Related RNA-Binding Proteins.
Ming R; Li X; Wang E; Wei J; Liu B; Zhou P; Yu W; Zong S; Xiao H
Front Oncol; 2022; 12():795781. PubMed ID: 35449571
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of a prognostic model related to pyroptosis-related genes for esophageal squamous cell carcinoma using bioinformatics analysis.
Zhang W; Zhang P; Jiang J; Peng K; Shen Z; Kang M
J Thorac Dis; 2022 Aug; 14(8):2953-2969. PubMed ID: 36071753
[TBL] [Abstract][Full Text] [Related]
38. Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma.
Cui H; Weng Y; Ding N; Cheng C; Wang L; Zhou Y; Zhang L; Cui Y; Zhang W
Front Oncol; 2021; 11():650891. PubMed ID: 34336650
[TBL] [Abstract][Full Text] [Related]
39. Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index.
Wu R; Ma R; Duan X; Zhang J; Li K; Yu L; Zhang M; Liu P; Wang C
Front Immunol; 2023; 14():1236444. PubMed ID: 37841237
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory response-related genes predict prognosis in patients with HNSCC.
Jing SL; Afshari K; Guo ZC
Immunol Lett; 2023 Jul; 259():46-60. PubMed ID: 37279805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
